Anyone read Immutep topline data this morning ?. Making some good progress.
And what have we as SH recieved/heard ?.
Yes its great they are focusing on the patients and the science, but for FS abit more than a patient has been given their drug IV.
Anyone who wants to read, its located in commsec market sensitive reports.
Add to My Watchlist
What is My Watchlist?